ODAC reviewed Imfinzi in resectable lung cancer 26 July 2024 FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer based on AEGEAN Phase III trial results The…
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRKs Positive Pipeline News AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizers (PFE) phase III studies achieve primary…
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript AZN earnings call for the period ending June 30, 2024.…
AstraZeneca, Roche Intensify New Drug Push, Automakers Sink Post-Earnings | The Opening Trade 07/25 2 and half trillion dollar Thursday. Thats the market cap of firms reporting on the busiest day for European earnings.…
AstraZeneca shares fall despite guidance raise as drugmaker warns on income By Investing.com AstraZeneca shares fall despite guidance raise as drugmaker warns on income…
ROUNDUP: Astrazeneca erhöht Prognose - Kostenentwicklung sorgt Anleger CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat nach dem zweiten Quartal seine Jahresprognose angehoben. Umsatz und Gewinn je Aktie…
AstraZeneca posts very respectable first half results The drop in AstraZeneca shares on Thursday was more a consequence of a wider market selloff than disappointed with the…
WDH: Astrazeneca übertrifft Erwartungen im zweiten Quartal - Höhere Prognose (Tippfehler berichtigt) CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat nach einem starken zweiten Quartal seine Jahresprognose…
FTSE 100 live: Stocks rebound after hitting three-month low, mixed start for Wall Street FTSE 100 climbs 3 points to 8,156 Results out from AstraZeneca, Unilever, BAT, Lloyds ...and BT, Vodafone, Centrica, Airtel, Rentokil, Mitchells &...…